nodes	percent_of_prediction	percent_of_DWPC	metapath
Moxifloxacin—TOP2A—Teniposide—lymphatic system cancer	0.477	0.588	CbGbCtD
Moxifloxacin—TOP2A—Mitoxantrone—lymphatic system cancer	0.333	0.411	CbGbCtD
Moxifloxacin—TOP2A—Etoposide—Teniposide—lymphatic system cancer	0.00125	0.195	CbGdCrCtD
Moxifloxacin—TOP2A—Podofilox—Teniposide—lymphatic system cancer	0.000957	0.149	CbGdCrCtD
Moxifloxacin—TOP2A—Vindesine—Vincristine—lymphatic system cancer	0.000903	0.14	CbGdCrCtD
Moxifloxacin—TOP2A—Vinorelbine—Vincristine—lymphatic system cancer	0.00057	0.0884	CbGdCrCtD
Moxifloxacin—TOP2A—Cladribine—Fludarabine—lymphatic system cancer	0.000431	0.0669	CbGdCrCtD
Moxifloxacin—TOP2A—Clofarabine—Fludarabine—lymphatic system cancer	0.000398	0.0618	CbGdCrCtD
Moxifloxacin—TOP2A—Vinblastine—Vincristine—lymphatic system cancer	0.000392	0.0608	CbGdCrCtD
Moxifloxacin—TOP2A—Clofarabine—Cytarabine—lymphatic system cancer	0.000376	0.0584	CbGdCrCtD
Moxifloxacin—TOP2A—Gemcitabine—Cytarabine—lymphatic system cancer	0.000348	0.0541	CbGdCrCtD
Moxifloxacin—TOP2A—Cytarabine—Fludarabine—lymphatic system cancer	0.000339	0.0526	CbGdCrCtD
Moxifloxacin—TOP2A—Azacitidine—Fludarabine—lymphatic system cancer	0.000243	0.0377	CbGdCrCtD
Moxifloxacin—TOP2A—Azacitidine—Cytarabine—lymphatic system cancer	0.000229	0.0356	CbGdCrCtD
Moxifloxacin—Vomiting—Teniposide—lymphatic system cancer	0.00019	0.00104	CcSEcCtD
Moxifloxacin—Sepsis—Methotrexate—lymphatic system cancer	0.000189	0.00103	CcSEcCtD
Moxifloxacin—Agitation—Carmustine—lymphatic system cancer	0.000189	0.00103	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000189	0.00103	CcSEcCtD
Moxifloxacin—Asthenia—Fludarabine—lymphatic system cancer	0.000188	0.00103	CcSEcCtD
Moxifloxacin—Rash—Teniposide—lymphatic system cancer	0.000188	0.00103	CcSEcCtD
Moxifloxacin—Dermatitis—Teniposide—lymphatic system cancer	0.000188	0.00103	CcSEcCtD
Moxifloxacin—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000188	0.00102	CcSEcCtD
Moxifloxacin—Headache—Teniposide—lymphatic system cancer	0.000187	0.00102	CcSEcCtD
Moxifloxacin—Pruritus—Fludarabine—lymphatic system cancer	0.000186	0.00101	CcSEcCtD
Moxifloxacin—Back pain—Mitoxantrone—lymphatic system cancer	0.000185	0.00101	CcSEcCtD
Moxifloxacin—Leukopenia—Carmustine—lymphatic system cancer	0.000184	0.001	CcSEcCtD
Moxifloxacin—Anorexia—Bleomycin—lymphatic system cancer	0.000184	0.001	CcSEcCtD
Moxifloxacin—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000183	0.000997	CcSEcCtD
Moxifloxacin—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000182	0.000992	CcSEcCtD
Moxifloxacin—Anaemia—Vincristine—lymphatic system cancer	0.000182	0.00099	CcSEcCtD
Moxifloxacin—Agitation—Vincristine—lymphatic system cancer	0.000181	0.000984	CcSEcCtD
Moxifloxacin—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00018	0.000983	CcSEcCtD
Moxifloxacin—Photosensitivity—Methotrexate—lymphatic system cancer	0.00018	0.000983	CcSEcCtD
Moxifloxacin—Polyuria—Methotrexate—lymphatic system cancer	0.00018	0.000983	CcSEcCtD
Moxifloxacin—Hypotension—Bleomycin—lymphatic system cancer	0.00018	0.00098	CcSEcCtD
Moxifloxacin—Diarrhoea—Fludarabine—lymphatic system cancer	0.00018	0.000979	CcSEcCtD
Moxifloxacin—Convulsion—Carmustine—lymphatic system cancer	0.000178	0.000972	CcSEcCtD
Moxifloxacin—Hypertension—Carmustine—lymphatic system cancer	0.000178	0.000969	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000178	0.000968	CcSEcCtD
Moxifloxacin—Nausea—Teniposide—lymphatic system cancer	0.000178	0.000967	CcSEcCtD
Moxifloxacin—Anaemia—Mitoxantrone—lymphatic system cancer	0.000177	0.000964	CcSEcCtD
Moxifloxacin—Vertigo—Vincristine—lymphatic system cancer	0.000177	0.000962	CcSEcCtD
Moxifloxacin—Hepatic failure—Methotrexate—lymphatic system cancer	0.000176	0.00096	CcSEcCtD
Moxifloxacin—Leukopenia—Vincristine—lymphatic system cancer	0.000176	0.000959	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000175	0.000956	CcSEcCtD
Moxifloxacin—Chest pain—Carmustine—lymphatic system cancer	0.000175	0.000955	CcSEcCtD
Moxifloxacin—Myalgia—Carmustine—lymphatic system cancer	0.000175	0.000955	CcSEcCtD
Moxifloxacin—Anxiety—Carmustine—lymphatic system cancer	0.000175	0.000952	CcSEcCtD
Moxifloxacin—Paraesthesia—Bleomycin—lymphatic system cancer	0.000173	0.000942	CcSEcCtD
Moxifloxacin—Malaise—Mitoxantrone—lymphatic system cancer	0.000173	0.000941	CcSEcCtD
Moxifloxacin—Dyspnoea—Bleomycin—lymphatic system cancer	0.000172	0.000935	CcSEcCtD
Moxifloxacin—Renal failure acute—Methotrexate—lymphatic system cancer	0.000172	0.000935	CcSEcCtD
Moxifloxacin—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000171	0.000934	CcSEcCtD
Moxifloxacin—Convulsion—Vincristine—lymphatic system cancer	0.00017	0.000928	CcSEcCtD
Moxifloxacin—Hypertension—Vincristine—lymphatic system cancer	0.00017	0.000925	CcSEcCtD
Moxifloxacin—Confusional state—Carmustine—lymphatic system cancer	0.00017	0.000923	CcSEcCtD
Moxifloxacin—Oedema—Carmustine—lymphatic system cancer	0.000168	0.000916	CcSEcCtD
Moxifloxacin—Decreased appetite—Bleomycin—lymphatic system cancer	0.000167	0.000912	CcSEcCtD
Moxifloxacin—Myalgia—Vincristine—lymphatic system cancer	0.000167	0.000912	CcSEcCtD
Moxifloxacin—Visual disturbance—Methotrexate—lymphatic system cancer	0.000167	0.000911	CcSEcCtD
Moxifloxacin—Cough—Mitoxantrone—lymphatic system cancer	0.000167	0.00091	CcSEcCtD
Moxifloxacin—Vomiting—Fludarabine—lymphatic system cancer	0.000167	0.00091	CcSEcCtD
Moxifloxacin—Convulsion—Mitoxantrone—lymphatic system cancer	0.000166	0.000904	CcSEcCtD
Moxifloxacin—Rash—Fludarabine—lymphatic system cancer	0.000166	0.000902	CcSEcCtD
Moxifloxacin—Dermatitis—Fludarabine—lymphatic system cancer	0.000165	0.000901	CcSEcCtD
Moxifloxacin—Hypertension—Mitoxantrone—lymphatic system cancer	0.000165	0.000901	CcSEcCtD
Moxifloxacin—Pain—Bleomycin—lymphatic system cancer	0.000165	0.000897	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000165	0.000897	CcSEcCtD
Moxifloxacin—Headache—Fludarabine—lymphatic system cancer	0.000165	0.000896	CcSEcCtD
Moxifloxacin—Tachycardia—Carmustine—lymphatic system cancer	0.000164	0.000894	CcSEcCtD
Moxifloxacin—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000164	0.000892	CcSEcCtD
Moxifloxacin—Myalgia—Mitoxantrone—lymphatic system cancer	0.000163	0.000888	CcSEcCtD
Moxifloxacin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000163	0.000888	CcSEcCtD
Moxifloxacin—Chest pain—Mitoxantrone—lymphatic system cancer	0.000163	0.000888	CcSEcCtD
Moxifloxacin—Anxiety—Mitoxantrone—lymphatic system cancer	0.000162	0.000885	CcSEcCtD
Moxifloxacin—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000162	0.000881	CcSEcCtD
Moxifloxacin—Lethargy—Methotrexate—lymphatic system cancer	0.000162	0.000881	CcSEcCtD
Moxifloxacin—Discomfort—Mitoxantrone—lymphatic system cancer	0.000161	0.000877	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00016	0.000874	CcSEcCtD
Moxifloxacin—Oedema—Vincristine—lymphatic system cancer	0.00016	0.000874	CcSEcCtD
Moxifloxacin—Anorexia—Carmustine—lymphatic system cancer	0.00016	0.000873	CcSEcCtD
Moxifloxacin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000159	0.000865	CcSEcCtD
Moxifloxacin—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000158	0.000863	CcSEcCtD
Moxifloxacin—Confusional state—Mitoxantrone—lymphatic system cancer	0.000158	0.000858	CcSEcCtD
Moxifloxacin—Nervous system disorder—Vincristine—lymphatic system cancer	0.000157	0.000857	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000157	0.000856	CcSEcCtD
Moxifloxacin—Hypotension—Carmustine—lymphatic system cancer	0.000157	0.000856	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000156	0.000851	CcSEcCtD
Moxifloxacin—Oedema—Mitoxantrone—lymphatic system cancer	0.000156	0.000851	CcSEcCtD
Moxifloxacin—Nausea—Fludarabine—lymphatic system cancer	0.000156	0.00085	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000155	0.000845	CcSEcCtD
Moxifloxacin—Shock—Mitoxantrone—lymphatic system cancer	0.000154	0.000838	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000153	0.000834	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000153	0.000834	CcSEcCtD
Moxifloxacin—Urticaria—Bleomycin—lymphatic system cancer	0.000153	0.000833	CcSEcCtD
Moxifloxacin—Anorexia—Vincristine—lymphatic system cancer	0.000153	0.000833	CcSEcCtD
Moxifloxacin—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000153	0.000831	CcSEcCtD
Moxifloxacin—Body temperature increased—Bleomycin—lymphatic system cancer	0.000152	0.000829	CcSEcCtD
Moxifloxacin—Insomnia—Carmustine—lymphatic system cancer	0.000152	0.000828	CcSEcCtD
Moxifloxacin—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000152	0.000827	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000151	0.000823	CcSEcCtD
Moxifloxacin—Paraesthesia—Carmustine—lymphatic system cancer	0.000151	0.000822	CcSEcCtD
Moxifloxacin—Mood swings—Methotrexate—lymphatic system cancer	0.00015	0.000818	CcSEcCtD
Moxifloxacin—Hypotension—Vincristine—lymphatic system cancer	0.00015	0.000817	CcSEcCtD
Moxifloxacin—Dyspnoea—Carmustine—lymphatic system cancer	0.00015	0.000816	CcSEcCtD
Moxifloxacin—Somnolence—Carmustine—lymphatic system cancer	0.000149	0.000814	CcSEcCtD
Moxifloxacin—Anorexia—Mitoxantrone—lymphatic system cancer	0.000149	0.000812	CcSEcCtD
Moxifloxacin—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000146	0.000797	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000146	0.000796	CcSEcCtD
Moxifloxacin—Decreased appetite—Carmustine—lymphatic system cancer	0.000146	0.000796	CcSEcCtD
Moxifloxacin—Hypotension—Mitoxantrone—lymphatic system cancer	0.000146	0.000796	CcSEcCtD
Moxifloxacin—Insomnia—Vincristine—lymphatic system cancer	0.000145	0.000791	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000145	0.000791	CcSEcCtD
Moxifloxacin—Paraesthesia—Vincristine—lymphatic system cancer	0.000144	0.000785	CcSEcCtD
Moxifloxacin—Pain—Carmustine—lymphatic system cancer	0.000144	0.000783	CcSEcCtD
Moxifloxacin—Constipation—Carmustine—lymphatic system cancer	0.000144	0.000783	CcSEcCtD
Moxifloxacin—Breast disorder—Methotrexate—lymphatic system cancer	0.000143	0.00078	CcSEcCtD
Moxifloxacin—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000143	0.000777	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000142	0.000776	CcSEcCtD
Moxifloxacin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000142	0.000773	CcSEcCtD
Moxifloxacin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00014	0.000764	CcSEcCtD
Moxifloxacin—Decreased appetite—Vincristine—lymphatic system cancer	0.00014	0.00076	CcSEcCtD
Moxifloxacin—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000139	0.000759	CcSEcCtD
Moxifloxacin—Somnolence—Mitoxantrone—lymphatic system cancer	0.000139	0.000757	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000139	0.000755	CcSEcCtD
Moxifloxacin—Feeling abnormal—Carmustine—lymphatic system cancer	0.000139	0.000755	CcSEcCtD
Moxifloxacin—Fatigue—Vincristine—lymphatic system cancer	0.000138	0.000754	CcSEcCtD
Moxifloxacin—Asthenia—Bleomycin—lymphatic system cancer	0.000138	0.000753	CcSEcCtD
Moxifloxacin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000138	0.000749	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000137	0.000749	CcSEcCtD
Moxifloxacin—Constipation—Vincristine—lymphatic system cancer	0.000137	0.000748	CcSEcCtD
Moxifloxacin—Pain—Vincristine—lymphatic system cancer	0.000137	0.000748	CcSEcCtD
Moxifloxacin—Asthma—Methotrexate—lymphatic system cancer	0.000137	0.000746	CcSEcCtD
Moxifloxacin—Pruritus—Bleomycin—lymphatic system cancer	0.000136	0.000742	CcSEcCtD
Moxifloxacin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000136	0.00074	CcSEcCtD
Moxifloxacin—Eosinophilia—Methotrexate—lymphatic system cancer	0.000136	0.000739	CcSEcCtD
Moxifloxacin—Fatigue—Mitoxantrone—lymphatic system cancer	0.000135	0.000734	CcSEcCtD
Moxifloxacin—Pancreatitis—Methotrexate—lymphatic system cancer	0.000134	0.000731	CcSEcCtD
Moxifloxacin—Constipation—Mitoxantrone—lymphatic system cancer	0.000134	0.000728	CcSEcCtD
Moxifloxacin—Pain—Mitoxantrone—lymphatic system cancer	0.000134	0.000728	CcSEcCtD
Moxifloxacin—Body temperature increased—Carmustine—lymphatic system cancer	0.000133	0.000724	CcSEcCtD
Moxifloxacin—Abdominal pain—Carmustine—lymphatic system cancer	0.000133	0.000724	CcSEcCtD
Moxifloxacin—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000131	0.000715	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000131	0.000715	CcSEcCtD
Moxifloxacin—Pancytopenia—Methotrexate—lymphatic system cancer	0.00013	0.000708	CcSEcCtD
Moxifloxacin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000129	0.000702	CcSEcCtD
Moxifloxacin—Dysuria—Methotrexate—lymphatic system cancer	0.000128	0.000697	CcSEcCtD
Moxifloxacin—Neutropenia—Methotrexate—lymphatic system cancer	0.000128	0.000697	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000128	0.000696	CcSEcCtD
Moxifloxacin—Abdominal pain—Vincristine—lymphatic system cancer	0.000127	0.000691	CcSEcCtD
Moxifloxacin—Body temperature increased—Vincristine—lymphatic system cancer	0.000127	0.000691	CcSEcCtD
Moxifloxacin—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000125	0.000681	CcSEcCtD
Moxifloxacin—Urticaria—Mitoxantrone—lymphatic system cancer	0.000124	0.000676	CcSEcCtD
Moxifloxacin—Hypersensitivity—Carmustine—lymphatic system cancer	0.000124	0.000675	CcSEcCtD
Moxifloxacin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000124	0.000673	CcSEcCtD
Moxifloxacin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000124	0.000673	CcSEcCtD
Moxifloxacin—Pneumonia—Methotrexate—lymphatic system cancer	0.000123	0.000669	CcSEcCtD
Moxifloxacin—Vomiting—Bleomycin—lymphatic system cancer	0.000122	0.000667	CcSEcCtD
Moxifloxacin—Infestation NOS—Methotrexate—lymphatic system cancer	0.000122	0.000665	CcSEcCtD
Moxifloxacin—Infestation—Methotrexate—lymphatic system cancer	0.000122	0.000665	CcSEcCtD
Moxifloxacin—Depression—Methotrexate—lymphatic system cancer	0.000122	0.000663	CcSEcCtD
Moxifloxacin—Rash—Bleomycin—lymphatic system cancer	0.000121	0.000661	CcSEcCtD
Moxifloxacin—Dermatitis—Bleomycin—lymphatic system cancer	0.000121	0.000661	CcSEcCtD
Moxifloxacin—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000121	0.000659	CcSEcCtD
Moxifloxacin—Asthenia—Carmustine—lymphatic system cancer	0.000121	0.000657	CcSEcCtD
Moxifloxacin—Renal failure—Methotrexate—lymphatic system cancer	0.00012	0.000654	CcSEcCtD
Moxifloxacin—Stomatitis—Methotrexate—lymphatic system cancer	0.000119	0.000648	CcSEcCtD
Moxifloxacin—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000119	0.000646	CcSEcCtD
Moxifloxacin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000118	0.000644	CcSEcCtD
Moxifloxacin—Sweating—Methotrexate—lymphatic system cancer	0.000117	0.000638	CcSEcCtD
Moxifloxacin—Haematuria—Methotrexate—lymphatic system cancer	0.000116	0.000634	CcSEcCtD
Moxifloxacin—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000115	0.000629	CcSEcCtD
Moxifloxacin—Epistaxis—Methotrexate—lymphatic system cancer	0.000115	0.000627	CcSEcCtD
Moxifloxacin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000115	0.000627	CcSEcCtD
Moxifloxacin—Asthenia—Vincristine—lymphatic system cancer	0.000115	0.000627	CcSEcCtD
Moxifloxacin—Diarrhoea—Carmustine—lymphatic system cancer	0.000115	0.000627	CcSEcCtD
Moxifloxacin—Nausea—Bleomycin—lymphatic system cancer	0.000114	0.000623	CcSEcCtD
Moxifloxacin—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000114	0.000621	CcSEcCtD
Moxifloxacin—Asthenia—Mitoxantrone—lymphatic system cancer	0.000112	0.000611	CcSEcCtD
Moxifloxacin—Dizziness—Carmustine—lymphatic system cancer	0.000111	0.000606	CcSEcCtD
Moxifloxacin—Haemoglobin—Methotrexate—lymphatic system cancer	0.00011	0.0006	CcSEcCtD
Moxifloxacin—Diarrhoea—Vincristine—lymphatic system cancer	0.00011	0.000598	CcSEcCtD
Moxifloxacin—Hepatitis—Methotrexate—lymphatic system cancer	0.00011	0.000597	CcSEcCtD
Moxifloxacin—Haemorrhage—Methotrexate—lymphatic system cancer	0.00011	0.000597	CcSEcCtD
Moxifloxacin—Pharyngitis—Methotrexate—lymphatic system cancer	0.000109	0.000593	CcSEcCtD
Moxifloxacin—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000108	0.00059	CcSEcCtD
Moxifloxacin—Urethral disorder—Methotrexate—lymphatic system cancer	0.000107	0.000585	CcSEcCtD
Moxifloxacin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000107	0.000583	CcSEcCtD
Moxifloxacin—Vomiting—Carmustine—lymphatic system cancer	0.000107	0.000582	CcSEcCtD
Moxifloxacin—Dizziness—Vincristine—lymphatic system cancer	0.000106	0.000578	CcSEcCtD
Moxifloxacin—Rash—Carmustine—lymphatic system cancer	0.000106	0.000577	CcSEcCtD
Moxifloxacin—Dermatitis—Carmustine—lymphatic system cancer	0.000106	0.000577	CcSEcCtD
Moxifloxacin—Visual impairment—Methotrexate—lymphatic system cancer	0.000106	0.000575	CcSEcCtD
Moxifloxacin—Headache—Carmustine—lymphatic system cancer	0.000105	0.000574	CcSEcCtD
Moxifloxacin—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000104	0.000565	CcSEcCtD
Moxifloxacin—Eye disorder—Methotrexate—lymphatic system cancer	0.000102	0.000558	CcSEcCtD
Moxifloxacin—Tinnitus—Methotrexate—lymphatic system cancer	0.000102	0.000557	CcSEcCtD
Moxifloxacin—Vomiting—Vincristine—lymphatic system cancer	0.000102	0.000556	CcSEcCtD
Moxifloxacin—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000102	0.000554	CcSEcCtD
Moxifloxacin—Rash—Vincristine—lymphatic system cancer	0.000101	0.000551	CcSEcCtD
Moxifloxacin—Dermatitis—Vincristine—lymphatic system cancer	0.000101	0.000551	CcSEcCtD
Moxifloxacin—Headache—Vincristine—lymphatic system cancer	0.000101	0.000548	CcSEcCtD
Moxifloxacin—Nausea—Carmustine—lymphatic system cancer	9.99e-05	0.000544	CcSEcCtD
Moxifloxacin—Angiopathy—Methotrexate—lymphatic system cancer	9.94e-05	0.000542	CcSEcCtD
Moxifloxacin—Vomiting—Mitoxantrone—lymphatic system cancer	9.94e-05	0.000541	CcSEcCtD
Moxifloxacin—Immune system disorder—Methotrexate—lymphatic system cancer	9.9e-05	0.000539	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Methotrexate—lymphatic system cancer	9.88e-05	0.000538	CcSEcCtD
Moxifloxacin—Rash—Mitoxantrone—lymphatic system cancer	9.85e-05	0.000537	CcSEcCtD
Moxifloxacin—Dermatitis—Mitoxantrone—lymphatic system cancer	9.85e-05	0.000536	CcSEcCtD
Moxifloxacin—Chills—Methotrexate—lymphatic system cancer	9.83e-05	0.000536	CcSEcCtD
Moxifloxacin—Headache—Mitoxantrone—lymphatic system cancer	9.79e-05	0.000533	CcSEcCtD
Moxifloxacin—Mental disorder—Methotrexate—lymphatic system cancer	9.6e-05	0.000523	CcSEcCtD
Moxifloxacin—Malnutrition—Methotrexate—lymphatic system cancer	9.54e-05	0.00052	CcSEcCtD
Moxifloxacin—Erythema—Methotrexate—lymphatic system cancer	9.54e-05	0.00052	CcSEcCtD
Moxifloxacin—Nausea—Vincristine—lymphatic system cancer	9.53e-05	0.000519	CcSEcCtD
Moxifloxacin—Dysgeusia—Methotrexate—lymphatic system cancer	9.34e-05	0.000509	CcSEcCtD
Moxifloxacin—Nausea—Mitoxantrone—lymphatic system cancer	9.28e-05	0.000506	CcSEcCtD
Moxifloxacin—Back pain—Methotrexate—lymphatic system cancer	9.23e-05	0.000503	CcSEcCtD
Moxifloxacin—Vision blurred—Methotrexate—lymphatic system cancer	8.99e-05	0.00049	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Methotrexate—lymphatic system cancer	8.85e-05	0.000482	CcSEcCtD
Moxifloxacin—Anaemia—Methotrexate—lymphatic system cancer	8.82e-05	0.00048	CcSEcCtD
Moxifloxacin—Malaise—Methotrexate—lymphatic system cancer	8.6e-05	0.000469	CcSEcCtD
Moxifloxacin—Vertigo—Methotrexate—lymphatic system cancer	8.57e-05	0.000467	CcSEcCtD
Moxifloxacin—Leukopenia—Methotrexate—lymphatic system cancer	8.54e-05	0.000465	CcSEcCtD
Moxifloxacin—Cough—Methotrexate—lymphatic system cancer	8.33e-05	0.000454	CcSEcCtD
Moxifloxacin—Convulsion—Methotrexate—lymphatic system cancer	8.27e-05	0.00045	CcSEcCtD
Moxifloxacin—Myalgia—Methotrexate—lymphatic system cancer	8.12e-05	0.000442	CcSEcCtD
Moxifloxacin—Arthralgia—Methotrexate—lymphatic system cancer	8.12e-05	0.000442	CcSEcCtD
Moxifloxacin—Chest pain—Methotrexate—lymphatic system cancer	8.12e-05	0.000442	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	8.07e-05	0.000439	CcSEcCtD
Moxifloxacin—Discomfort—Methotrexate—lymphatic system cancer	8.03e-05	0.000437	CcSEcCtD
Moxifloxacin—Confusional state—Methotrexate—lymphatic system cancer	7.85e-05	0.000428	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Methotrexate—lymphatic system cancer	7.79e-05	0.000424	CcSEcCtD
Moxifloxacin—Nervous system disorder—Methotrexate—lymphatic system cancer	7.64e-05	0.000416	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Methotrexate—lymphatic system cancer	7.62e-05	0.000415	CcSEcCtD
Moxifloxacin—Skin disorder—Methotrexate—lymphatic system cancer	7.56e-05	0.000412	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Methotrexate—lymphatic system cancer	7.53e-05	0.00041	CcSEcCtD
Moxifloxacin—Anorexia—Methotrexate—lymphatic system cancer	7.42e-05	0.000404	CcSEcCtD
Moxifloxacin—Hypotension—Methotrexate—lymphatic system cancer	7.28e-05	0.000396	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	7.09e-05	0.000386	CcSEcCtD
Moxifloxacin—Insomnia—Methotrexate—lymphatic system cancer	7.04e-05	0.000384	CcSEcCtD
Moxifloxacin—Paraesthesia—Methotrexate—lymphatic system cancer	6.99e-05	0.000381	CcSEcCtD
Moxifloxacin—Dyspnoea—Methotrexate—lymphatic system cancer	6.94e-05	0.000378	CcSEcCtD
Moxifloxacin—Somnolence—Methotrexate—lymphatic system cancer	6.92e-05	0.000377	CcSEcCtD
Moxifloxacin—Dyspepsia—Methotrexate—lymphatic system cancer	6.85e-05	0.000373	CcSEcCtD
Moxifloxacin—Decreased appetite—Methotrexate—lymphatic system cancer	6.77e-05	0.000369	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	6.72e-05	0.000366	CcSEcCtD
Moxifloxacin—Fatigue—Methotrexate—lymphatic system cancer	6.71e-05	0.000366	CcSEcCtD
Moxifloxacin—Pain—Methotrexate—lymphatic system cancer	6.66e-05	0.000363	CcSEcCtD
Moxifloxacin—Feeling abnormal—Methotrexate—lymphatic system cancer	6.42e-05	0.00035	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	6.37e-05	0.000347	CcSEcCtD
Moxifloxacin—Urticaria—Methotrexate—lymphatic system cancer	6.19e-05	0.000337	CcSEcCtD
Moxifloxacin—Body temperature increased—Methotrexate—lymphatic system cancer	6.16e-05	0.000335	CcSEcCtD
Moxifloxacin—Abdominal pain—Methotrexate—lymphatic system cancer	6.16e-05	0.000335	CcSEcCtD
Moxifloxacin—Hypersensitivity—Methotrexate—lymphatic system cancer	5.74e-05	0.000313	CcSEcCtD
Moxifloxacin—Asthenia—Methotrexate—lymphatic system cancer	5.59e-05	0.000304	CcSEcCtD
Moxifloxacin—Pruritus—Methotrexate—lymphatic system cancer	5.51e-05	0.0003	CcSEcCtD
Moxifloxacin—Diarrhoea—Methotrexate—lymphatic system cancer	5.33e-05	0.00029	CcSEcCtD
Moxifloxacin—Dizziness—Methotrexate—lymphatic system cancer	5.15e-05	0.00028	CcSEcCtD
Moxifloxacin—Vomiting—Methotrexate—lymphatic system cancer	4.95e-05	0.00027	CcSEcCtD
Moxifloxacin—Rash—Methotrexate—lymphatic system cancer	4.91e-05	0.000267	CcSEcCtD
Moxifloxacin—Dermatitis—Methotrexate—lymphatic system cancer	4.91e-05	0.000267	CcSEcCtD
Moxifloxacin—Headache—Methotrexate—lymphatic system cancer	4.88e-05	0.000266	CcSEcCtD
Moxifloxacin—Nausea—Methotrexate—lymphatic system cancer	4.63e-05	0.000252	CcSEcCtD
